About Us

Who We Are


Anatomise Biostats is a boutique statistical consultancy specialising in biostatistics and bioinformatics services. We tailor advanced statistical solutions for clients in the pharmaceutical, and medtech
industries. Our bespoke clinical trials packages include integrated biostatistics, statistical programming, bioinformatics and data science.

Core Expertise:

  • Design and statistical analysis of R&D, pre-clinical and clinical trials for biotech and pharma start-ups and SMEs, including master protocols.
  • Advanced statistical or computational analysis and modelling of bio-medical, genomics and public health data.

We take a multi-disciplinary approach and keep up-to date with the latest analysis techniques, such as Bayesian modelling and network analysis, so that we can provide the most comprehensive statistical services to suit evolving client needs.

Who We Work With

We provide comprehensive clinical trial services to biotech, medtech/medical device and pharmaceutical start-ups and SMEs globally.

Additonally, we consult to:

  • Clinical researchers in both public and private sectors.
  • Academic researchers in medical and life sciences.
  • Legal professionals handling medical malpractice, negligence, injury, and insurance cases.

How We Collaborate

Anatomise Biostats differs from a full-service CRO in that we specialise in the data and methodology side of a project. In delivering our expert biostatistics, genomics, data analysis and statistical reporting services we work alongside traditional CROs who have a broader focus on execution of the overall research project.

For bigger projects we partner with CROs who outsource their biostatistical and bioinformatics capabilities in order to offer their customers a more tailored and project specific study design.

For smaller pre-trial and R&D projects we work directly with biomedical researchers in the design, analysis and reporting of their study, without the need for a third party CRO. This allows resources to be utilised efficiently at the early pre-trial stage.

Our expert biostatisticians can perform independent audit of any study design, data collection related methodology, statistical analyses or reported findings that have arisen prior to our involvement. We can also aid in the interpretation of any existing study results.

Our modular pricing approach for clinical trials allows ensures cost is known upfront while allowing a flexible solution tailored to your project’s specific requirements:

Core Services: Our core clinical trials package covers essential biostatistics, quality control, and statistical programming for clinical trials. This means you have a dedicated and pre-vetted biostatistics team for your clinical trial, without the need to spend months recruiting and onboarding individuals. This is billed in six-month instalments to align with your project’s timeline.

Add-On Services: Enhance your core package by adding specialised services such as bioinformatics or data science for £50,000 per annum. These can be selected based on your project’s unique needs.

Our modular approach to pricing was implemented in response to feedback from industry and is designed to simplify the clinical trial process and enhance transparency around service costs.

Some indirect benefits of working with us

  • Increase cost-effectiveness and optimise research budget
  • Streamline the execution of clinical trials with enhanced efficiency.
  • Reduce your risk of pursuing un-productive research trajectories.
  • Increase precision to ensure the insights from your research are as accurate as possible

General Service Overview


Our consultants are experts across a wide range of clinical sciences, including oncology, rare disease, haematology, medical and diagnostic devices, orthodontics, neuroscience, genomic analysis, and clinical psychology.

We support clients by:

  • Designing clinical studies, including power and sample size calculations.
  • Developing statistical analysis plans (SAPs).
  • Conducting thorough statistical analyses and generating publication-ready reports (SARs).
  • Supporting regulatory approval of novel therapeutics via clinical trials and pilot studies.

For legal clients, we offer scoping reviews, meta-analysis, and the development of advanced statistical models.

Our Philosophy

At Anatomise Biostats we take a modern and dynamic approach to research collaboration.
The field of medicine and the scope of associated research areas encompass an increasingly broad domain. As knowledge and technology expands, many different sub-disciplines are emerging that previously had not existed, and research areas are becoming highly intricate and specialised.  In addition to this, a multidisciplinary landscape is emerging with previously disparate areas of study merging to constitute entirely new domains.

In an attempt to address this and to provide the highest standards of service to clients, we have taken the philosophy of medical specialisation and applied it to our biostatistical services. We employ the services of a number of highly specialised biostatisticians who take on the bulk of their projects within a single field. Due to the ever increasing complexity of data and the associated analytical approaches required to satisfactorily extract insights, we believe that this is by far the best approach. As we have specialists in multiple fields, this expertise can be combined to address research questions that blur the bounds of previously distinct sub-disciplines.

As strong statistical knowledge is the cornerstone of any scientific research endeavour, our expert biostatisticians provide detailed support throughout the entire life cycle of your project from study design and regulatory concerns, sampling and randomisation, data services and statistical analysis, all the way to reporting and publication.

Having a biostatistician who specialises in a particular area benefits you as they can more efficiently apply their sometimes quite obscure knowledge from previous projects to benefit your research in the same niche.

We take pride in contributing to clinical and life sciences research that is of high integrity and impeccable standard so that insights from future research continue to be built upon a solid foundation.